Skip to main content
HOWL
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
5
Price
$0.68
Mkt Cap
$33.046M
52W Low
$0.53
52W High
$2.38
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, HOWL was trading at $0.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $33M. The 52-week trading range was $0.53 to $2.38. This filing was assessed with an importance score of 5 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HOWL - Latest Insights

HOWL
Apr 29, 2026, 4:48 PM EDT
Filing Type: 144
Importance Score:
7
Institutional Shareholder Files Intent to Sell Amidst Going Concern Warning
Sentiment: Negative
View Wiseek Article
HOWL
Mar 27, 2026, 7:12 AM EDT
Filing Type: 10-K
Importance Score:
9
Werewolf Therapeutics Discloses Substantial Doubt About Going Concern, Announces 64% Workforce Reduction, and Explores Strategic Alternatives
Sentiment: Negative
View Wiseek Article
HOWL
Mar 27, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
9
Werewolf Therapeutics Explores Strategic Alternatives, Including Potential Sale, Amidst Short Cash Runway
Sentiment: Negative
View Wiseek Article
HOWL
Mar 27, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Werewolf Therapeutics Explores Strategic Options Including Company Sale, Merger
Sentiment: Positive
View Wiseek Article
HOWL
Feb 24, 2026, 5:26 PM EST
Filing Type: 8-K
Importance Score:
9
Werewolf Therapeutics Engages Piper Sandler to Explore Strategic Alternatives Amidst Prior Workforce Cuts and Delisting Threat
Sentiment: Negative
View Wiseek Article
HOWL
Feb 13, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
9
Werewolf Therapeutics announces 64% workforce reduction, CFO/CMO resignations amid strategic review
Sentiment: Negative
View Wiseek Article
HOWL
Feb 06, 2026, 4:41 PM EST
Filing Type: 8-K
Importance Score:
9
Werewolf Therapeutics Receives Nasdaq Delisting Notice for Sub-$1.00 Stock Price
Sentiment: Negative
View Wiseek Article
HOWL
Jan 16, 2026, 5:36 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Investor Group Sells $379K in Shares, Reducing Stake Amidst Lows
Sentiment: Negative
View Wiseek Article
HOWL
Jan 06, 2026, 4:54 PM EST
Filing Type: 144
Importance Score:
7
Major Investor Files Intent to Sell Additional Shares Amidst Ongoing Divestment
Sentiment: Negative
View Wiseek Article